genome sequencing - AI-Tech Park

Engine Biosciences Announces $43M Round to Decipher Genetic Codes

Business WireMay 26, 2021May 26, 2021

by Business WireMay 26, 2021May 26, 20210480

Important Findings from Pioneering Platform Advancing Drug Discovery and Development to Impact Treatments for Multiple Cancers Engine Biosciences (“Engine”) today announced the successful completion of an...

Genomics

Moderna and Aldevron Expand Partnership for mRNA Vaccine

Business WireMay 25, 2021May 25, 2021

by Business WireMay 25, 2021May 25, 20210520

Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and...

Genomics

Genomic Medicine Company Sangamo Therapeutics Appoints New CFO

Business WireMay 25, 2021May 25, 2021

by Business WireMay 25, 2021May 25, 20210423

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Prathyusha Duraibabu, CPA, MBA as Senior Vice President and Chief Financial...

Genomics

Brooklyn Strengthens Investment in mRNA Tech Platform with $20M

Business WireMay 25, 2021May 25, 2021

by Business WireMay 25, 2021May 25, 20210436

Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company currently focused on exploring the role that cytokine and gene editing/cell therapy can have in treating...

Genomics

Gene-editing Co. Kiromic Submits FDA IND for a Clinical Trial

Business WireMay 25, 2021May 25, 2021

by Business WireMay 25, 2021May 25, 20210504

Kiromic achieves key milestone for this first-in-human Phase 1 clinical trial with a target derived by Kiromic’s AI platform. Kiromic Biopharma, Inc. (Nasdaq: KRBP), an...

Genomics

Gene-editing Co. Kiromic Announces Identification of Novel Targets

Business WireMay 21, 2021May 21, 2021

by Business WireMay 21, 2021May 21, 20210433

Kiromic Biopharma, Inc. (Nasdaq: KRBP) is an immuno-oncology target discovery and gene-editing company with a proprietary artificial intelligence neural network platform (Diamond AI) that is...

Genomics

2bPrecise Genomic EHR Mentor and MMC to Present at AMIA 2021

Business WireMay 18, 2021May 18, 2021

by Business WireMay 18, 2021May 18, 20210462

Leader in precision medicine solutions and multispecialty clinic customerto discuss the promise of genetic data at the point of care 2bPrecise, a leader in precision...

Genomics

Genomics for Cancer Leader Personalis to Present on ImmunoID NeXT

Business WireMay 18, 2021May 18, 2021

by Business WireMay 18, 2021May 18, 20210561

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present at Biomarkers Week Online 2021. The presentation, titled...

Genomics

NanoString’s GeoMx MWT Atlas Expands Spatial Genomics Leadership

Business WireMay 17, 2021May 17, 2021

by Business WireMay 17, 2021May 17, 20210502

Accelerating Discovery by Providing High Throughput Spatial Analysis of any RNA Target in the Primary Model Organism for Discovery NanoString Technologies, Inc. (NASDAQ: NSTG), a...

Genomics

Veracyte Announces Percepta Genomic Atlas Detects Gene Alterations

Business WireMay 17, 2021May 17, 2021

by Business WireMay 17, 2021May 17, 20210510

Veracyte, Inc. (Nasdaq: VCYT) announced today new data demonstrating the ability of the Percepta® Genomic Atlas to detect alterations that may inform lung cancer treatment decisions...

Tag : genome sequencing

Engine Biosciences Announces $43M Round to Decipher Genetic Codes

Moderna and Aldevron Expand Partnership for mRNA Vaccine

Genomic Medicine Company Sangamo Therapeutics Appoints New CFO

Brooklyn Strengthens Investment in mRNA Tech Platform with $20M

Gene-editing Co. Kiromic Submits FDA IND for a Clinical Trial

Gene-editing Co. Kiromic Announces Identification of Novel Targets

2bPrecise Genomic EHR Mentor and MMC to Present at AMIA 2021

Genomics for Cancer Leader Personalis to Present on ImmunoID NeXT

NanoString’s GeoMx MWT Atlas Expands Spatial Genomics Leadership

Veracyte Announces Percepta Genomic Atlas Detects Gene Alterations

New Lumu Defender Capabilities Provide Visibility Beyond the Network

Vigil: The First Open-Source AI SOC Built with a LLM-native Architecture

CyberProof Unveils Reveal360 Hub for Security and Business Outcomes

Cybercriminals Access Enterprise PCs 76 Days a Year: Study

AITech Interview with Bobby Samuels, Chief Executive Officer & Co-founder, Protege

New Lumu Defender Capabilities Provide Visibility Beyond the...

Vigil: The First Open-Source AI SOC Built with...

CyberProof Unveils Reveal360 Hub for Security and Business...

Cybercriminals Access Enterprise PCs 76 Days a Year:...

AITech Interview with Bobby Samuels, Chief Executive Officer...

QUICK LINKS

Our Publications